Lucatumumab Chemical Properties

storage temp. 

Store at -20°C

form 

Liquid

color 

Colorless to light yellow

Lucatumumab Usage And Synthesis

Uses

Lucatumumab (HCD122) is a fully human anti-CD40 antagonist monoclonal antibody, which blocks CD40/CD40L-mediated signaling. Lucatumumab efficiently mediates antibody-dependent cell-mediated cytotoxicity (ADCC) and clearance of tumor cells, can be used for refractory lymphomas, CLL and multiple myeloma research[1][2].

IC 50

CD40

References

[1] Luqman M, et al. The antileukemia activity of a human anti-CD40 antagonist antibody, HCD122, on human chronic lymphocytic leukemia cells. Blood. 2008 Aug 1;112(3):711-20. DOI:10.1182/blood-2007-04-084756
[2] Drgona L, et al. ESCMID Study Group for Infections in Compromised Hosts (ESGICH) Consensus Document on the safety of targeted and biological therapies: an infectious diseases perspective (Agents targeting lymphoid or myeloid cells surface antigens [II]: CD22, CD30, CD33, CD38, CD40, SLAMF-7 and CCR4). Clin Microbiol Infect. 2018 Jun;24 Suppl 2:S83-S94. DOI:10.1016/j.cmi.2018.03.022

Lucatumumab(903512-50-5)Related Product Information

• Selicrelumab
• Semorinemab
• Rovalpituzumab
• ipilimumab
• Plozalizumab
• Durvalumab
• Dalotuzumab
• Iratumumab
• Cusatuzumab
• Leronlimab